Bone Marrow Transplantation in Treating Patients With Lymphoma
- First Posted Date
- 2004-05-26
- Last Posted Date
- 2012-07-30
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 45
- Registration Number
- NCT00002829
- Locations
- 🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
Eflornithine To Prevent Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2004-05-26
- Last Posted Date
- 2018-10-25
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 150
- Registration Number
- NCT00006079
- Locations
- 🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2004-05-24
- Last Posted Date
- 2012-07-30
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 75
- Registration Number
- NCT00003084
- Locations
- 🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2004-05-19
- Last Posted Date
- 2018-11-06
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 56
- Registration Number
- NCT00082732
- Locations
- 🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2004-05-19
- Last Posted Date
- 2015-05-14
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 33
- Registration Number
- NCT00082719
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant
Phase 2
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2004-05-19
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 46
- Registration Number
- NCT00082706
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2004-05-03
- Last Posted Date
- 2018-10-25
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 16
- Registration Number
- NCT00004246
- Locations
- 🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2004-04-30
- Last Posted Date
- 2012-07-30
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 90
- Registration Number
- NCT00003239
- Locations
- 🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's Disease
- First Posted Date
- 2004-04-28
- Last Posted Date
- 2012-02-20
- Lead Sponsor
- M.D. Anderson Cancer Center
- Registration Number
- NCT00005969
Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma
- First Posted Date
- 2004-04-27
- Last Posted Date
- 2012-04-05
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 13
- Registration Number
- NCT00081861
- Locations
- 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath